Nodular Lymphocyte Predominant Hodgkin Lymphoma has emerging NIH research funding with 1 grant totaling $570K.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Nodular Lymphocyte Predominant Hodgkin Lymphoma. Strongest funded area: Clinical Research. Largest gap: Epidemiology / Natural History.
7 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for nodular lymphocyte predominant Hodgkin lymphoma. Existing research activity suggests this may be a viable area for grant applications.
10 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for nodular lymphocyte predominant Hodgkin lymphoma. Existing research activity suggests this may be a viable area for grant applications.
7 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for nodular lymphocyte predominant Hodgkin lymphoma. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.